Understanding the Key Differences: Licensed Uses Matter
Wegovy vs Wegovy for weight management: Critical Licensing Differences
The most important distinction when comparing Wegovy vs Wegovy for weight management centres on their licensed indications in the UK. Wegovy is specifically licensed by the MHRA for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Ozempic, conversely, is licensed exclusively for type 2 diabetes treatment and cannot legally be promoted or prescribed for weight management purposes.
Both medications contain the same active ingredient—semaglutide—but their different licensing means only Wegovy can be appropriately prescribed for weight management goals. At EverydayMeds, our GPhC-registered pharmacy (#9012878) ensures you receive the correct prescription-only medicine for your specific needs. This licensing distinction isn't just regulatory—it reflects different clinical trial programmes, dosing schedules, and safety profiles established for each indication. When comparing Wegovy vs Wegovy for weight management, the choice becomes clear: Wegovy is the appropriate, legally compliant option.
Wegovy Pricing and In-Stock Availability Across All Doses
EverydayMeds maintains complete stock of all five Wegovy doses, addressing the availability concerns that have historically affected this prescription-only medicine. Single pen pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from code FIRST40, whilst returning customers can use DOSE25, applied at checkout to reach these final prices.
Our bundle options provide convenience for longer treatment periods, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first 12 weeks of dose escalation. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99. When evaluating Wegovy vs Wegovy for weight management costs, remember that only Wegovy represents appropriate, licensed treatment—making price comparisons with diabetes medications irrelevant for weight management goals. All orders include next-day cold-chain delivery once your clinical assessment receives prescriber approval.
Clinical Evidence Supporting Wegovy for Weight Management
The STEP trial programme provides robust evidence for Wegovy's effectiveness in weight management. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 demonstrated clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 showed 16% reduction when combined with intensive behavioural therapy.
The recent SELECT trial revealed an additional benefit: 20% reduction in major cardiovascular events (HR 0.80) among participants taking semaglutide. These trials specifically evaluated Wegovy's weight management indication, distinguishing it from diabetes-focused research. When considering Wegovy vs Wegovy for weight management evidence, it's crucial to recognise that only Wegovy has been studied and approved for this specific indication, ensuring appropriate clinical oversight and dosing protocols.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural hormone that regulates appetite and satiety. The medication works on brain appetite centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. This mechanism helps support adherence to reduced-calorie diets by addressing the physiological drivers of hunger and overeating. Unlike medications that work purely through absorption blocking or stimulant effects, Wegovy's GLP-1 action targets the body's natural weight regulation systems. The once-weekly FlexTouch pen delivery system maintains steady medication levels, providing consistent appetite support throughout the seven-day dosing interval. This mechanism explains why Wegovy must be used alongside dietary changes and increased physical activity—it enhances your body's natural responses to lifestyle modifications rather than replacing them.
Streamlined Ordering Process: Assessment to Delivery
Our ordering process begins with a comprehensive 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Qualified prescribers review each application, with standard processing taking 3 working days or express 24-hour review available for urgent needs. Once approved, your Wegovy prescription enters our cold-chain dispatch system, maintaining the required 2-8°C temperature throughout packaging and delivery. Next-day delivery ensures your medication arrives promptly while preserving its effectiveness and safety profile. This streamlined approach eliminates traditional pharmacy visits while maintaining full clinical oversight, ensuring you receive appropriate care for this prescription-only medicine.
Storage Requirements and Practical Considerations
Wegovy requires refrigerated storage at 2-8°C before first use, though it can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge. This 6-week room temperature stability provides significant practical advantages for travel or situations where refrigeration isn't immediately available. The FlexTouch pen system simplifies injection technique, with pre-measured doses eliminating calculation errors. Dose escalation follows a specific 4-week schedule: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance, designed to minimise gastrointestinal side effects while achieving therapeutic levels. Each pen contains four weekly doses, marked clearly for accurate administration throughout your treatment schedule.
Why UK Availability Matters for Wegovy vs Ozempic Weight Loss Decisions
Reliable UK supply chains have become increasingly important as demand for effective weight management treatments grows. EverydayMeds maintains direct relationships with Novo Nordisk, ensuring consistent stock levels across all five Wegovy doses without the supply interruptions that have affected other providers. This reliability becomes crucial when considering Wegovy vs Wegovy for weight management, as consistent treatment access supports better long-term outcomes. Our GPhC registration (#9012878) provides additional assurance that your medication sourcing meets UK regulatory standards.
The availability factor extends beyond simple stock levels—it encompasses appropriate clinical oversight, legal prescribing practices, and ongoing support throughout your weight management journey. When healthcare providers inappropriately suggest diabetes medications for weight loss, they create legal and safety concerns that don't exist with properly prescribed Wegovy. Our approach ensures you receive the correct prescription-only medicine through legitimate channels, supporting both immediate availability and long-term treatment success.
Complete Your Wegovy Assessment: Available Today
Ready to start your weight management journey with the appropriate, licensed medication? Complete our clinical assessment today to determine if Wegovy suits your specific needs and health profile. Our experienced prescribers evaluate each application individually, ensuring safe, appropriate treatment recommendations. Use code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing from £79.99. With all doses in stock and next-day delivery available, there's no need to wait or compromise on treatment quality. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step toward evidence-based weight management support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
